PL2211180T3 - Zastosowanie białka SATB2 jako markera do rozróżniania nowotworów jelita grubego od innych nowotworów - Google Patents
Zastosowanie białka SATB2 jako markera do rozróżniania nowotworów jelita grubego od innych nowotworówInfo
- Publication number
- PL2211180T3 PL2211180T3 PL10158956T PL10158956T PL2211180T3 PL 2211180 T3 PL2211180 T3 PL 2211180T3 PL 10158956 T PL10158956 T PL 10158956T PL 10158956 T PL10158956 T PL 10158956T PL 2211180 T3 PL2211180 T3 PL 2211180T3
- Authority
- PL
- Poland
- Prior art keywords
- marker
- cancers
- colorectal cancer
- satb2
- protein
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57419—Specifically defined cancers of colon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4703—Regulators; Modulating activity
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Physics & Mathematics (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06114954A EP1862803A1 (en) | 2006-06-02 | 2006-06-02 | Use of protein SATB2 as a marker for colorectal cancer |
US81661306P | 2006-06-27 | 2006-06-27 | |
EP07725799A EP2024747B1 (en) | 2006-06-02 | 2007-06-04 | Use of protein satb2 as a prognostic marker for colorectal cancer |
EP10158956A EP2211180B1 (en) | 2006-06-02 | 2007-06-04 | Use of protein SATB2 as a marker for distinguishing colorectal cancer from other cancers |
Publications (1)
Publication Number | Publication Date |
---|---|
PL2211180T3 true PL2211180T3 (pl) | 2011-11-30 |
Family
ID=36968849
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL10158956T PL2211180T3 (pl) | 2006-06-02 | 2007-06-04 | Zastosowanie białka SATB2 jako markera do rozróżniania nowotworów jelita grubego od innych nowotworów |
Country Status (11)
Country | Link |
---|---|
US (3) | US8067190B2 (pl) |
EP (3) | EP1862803A1 (pl) |
JP (2) | JP4990970B2 (pl) |
CN (2) | CN101460850A (pl) |
AT (2) | ATE514090T1 (pl) |
AU (1) | AU2007256391B2 (pl) |
CA (1) | CA2653952A1 (pl) |
DK (2) | DK2024747T3 (pl) |
ES (1) | ES2367412T3 (pl) |
PL (1) | PL2211180T3 (pl) |
WO (1) | WO2007140966A1 (pl) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100662821B1 (ko) * | 2006-04-05 | 2006-12-28 | 유니트마 주식회사 | 레시피언트 블록 성형용 몰드 및 이를 이용한 레시피언트블록의 제조방법 |
EP1862803A1 (en) | 2006-06-02 | 2007-12-05 | Atlas Antibodies AB | Use of protein SATB2 as a marker for colorectal cancer |
EP2107375A1 (en) * | 2008-03-31 | 2009-10-07 | Atlas Antibodies AB | Uses of WARS protein in cancer prognostics |
EP2172477A1 (en) * | 2008-10-06 | 2010-04-07 | Atlas Antibodies AB | Epitopes derived from SATB2 and uses thereof |
WO2010091763A1 (en) * | 2009-02-16 | 2010-08-19 | Atlas Antibodies Ab | Rbm3 as a marker for malignant melanoma prognosis |
ES2709056T3 (es) | 2014-05-13 | 2019-04-15 | Vastcon | La sobreexpresión de la metionina aminopeptidasa en la sangre periférica y las células mononucleares de la sangre periférica son un marcador para la detección, el diagnóstico y el pronóstico del cáncer colorrectal |
WO2016120853A1 (en) * | 2015-01-30 | 2016-08-04 | Glax Llc | Compositions and methods for monitoring, diagnosis, prognosis, detection, and treatment of cancer |
US20160258438A1 (en) * | 2015-03-05 | 2016-09-08 | Regal Beloit America, Inc. | Assembly, blower and associated method |
WO2016176446A2 (en) * | 2015-04-29 | 2016-11-03 | Geneoscopy, Llc | Colorectal cancer screening method and device |
WO2018081580A1 (en) | 2016-10-27 | 2018-05-03 | Geneoscopy, Llc | Detection method |
CN106841131A (zh) * | 2016-12-29 | 2017-06-13 | 上海交通大学 | 一种基于角蛋白自荧光作为预测检测肿瘤的生物标志物的检测方法及其应用 |
CA3136405A1 (en) | 2018-06-01 | 2019-12-05 | Geneoscopy, Inc. | Detection method for cancer using rna biomarkers |
JP2022502072A (ja) * | 2018-08-08 | 2022-01-11 | インディアン・インスティテュート・オブ・サイエンス・エデュケーション・アンド・リサーチ | がんの予後に関する向上されたバイオマーカーツールとしてのsatbファミリークロマチンオーガナイザーの複合発現パターン |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9828840D0 (en) | 1998-12-30 | 1999-02-17 | Univ Nottingham Trent | Prostate cancer associated genes and their products |
DE19932688B4 (de) | 1999-07-13 | 2009-10-08 | Scil Proteins Gmbh | Design von Beta-Faltblatt-Proteinen des gamma-II-kristallins antikörperähnlichen |
WO2003022126A2 (en) * | 2001-08-21 | 2003-03-20 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of colon cancer |
US20090215711A1 (en) * | 2004-04-30 | 2009-08-27 | Sagres Discovery, Inc. | Novel compositions and methods in cancer |
DE102004037860A1 (de) | 2004-08-04 | 2006-03-16 | Friedrich-Alexander-Universität Erlangen-Nürnberg | Turmormarker zur Diagnose von Karzinomen und/oder davon abstammender Metastasen |
JP5219029B2 (ja) * | 2005-05-02 | 2013-06-26 | 東レ株式会社 | 食道ガン及び食道ガン転移診断のための組成物及び方法 |
GB2435882A (en) | 2006-03-09 | 2007-09-12 | Bioinvent Int Ab | Detection and treatment of mantle cell lymphoma |
EP1862803A1 (en) | 2006-06-02 | 2007-12-05 | Atlas Antibodies AB | Use of protein SATB2 as a marker for colorectal cancer |
-
2006
- 2006-06-02 EP EP06114954A patent/EP1862803A1/en not_active Withdrawn
-
2007
- 2007-06-04 JP JP2009512511A patent/JP4990970B2/ja active Active
- 2007-06-04 CA CA002653952A patent/CA2653952A1/en not_active Abandoned
- 2007-06-04 AT AT10158956T patent/ATE514090T1/de not_active IP Right Cessation
- 2007-06-04 PL PL10158956T patent/PL2211180T3/pl unknown
- 2007-06-04 CN CNA2007800204929A patent/CN101460850A/zh active Pending
- 2007-06-04 AT AT07725799T patent/ATE513216T1/de not_active IP Right Cessation
- 2007-06-04 WO PCT/EP2007/004931 patent/WO2007140966A1/en active Application Filing
- 2007-06-04 EP EP10158956A patent/EP2211180B1/en active Active
- 2007-06-04 EP EP07725799A patent/EP2024747B1/en not_active Not-in-force
- 2007-06-04 US US12/302,248 patent/US8067190B2/en active Active
- 2007-06-04 ES ES10158956T patent/ES2367412T3/es active Active
- 2007-06-04 DK DK07725799.6T patent/DK2024747T3/da active
- 2007-06-04 CN CN201310187869.7A patent/CN103293307B/zh active Active
- 2007-06-04 AU AU2007256391A patent/AU2007256391B2/en not_active Ceased
- 2007-06-04 DK DK10158956.2T patent/DK2211180T3/da active
-
2011
- 2011-10-21 US US13/278,473 patent/US8241859B2/en not_active Expired - Fee Related
- 2011-10-28 JP JP2011237699A patent/JP5301630B2/ja not_active Expired - Fee Related
-
2012
- 2012-07-06 US US13/542,723 patent/US8465934B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN103293307A (zh) | 2013-09-11 |
US20120270956A1 (en) | 2012-10-25 |
ATE514090T1 (de) | 2011-07-15 |
DK2024747T3 (da) | 2011-09-19 |
EP2024747A1 (en) | 2009-02-18 |
CN101460850A (zh) | 2009-06-17 |
CA2653952A1 (en) | 2007-12-13 |
JP2012073260A (ja) | 2012-04-12 |
EP1862803A1 (en) | 2007-12-05 |
US20090220975A1 (en) | 2009-09-03 |
US8067190B2 (en) | 2011-11-29 |
DK2211180T3 (da) | 2011-09-26 |
AU2007256391B2 (en) | 2011-05-19 |
US20120028836A1 (en) | 2012-02-02 |
CN103293307B (zh) | 2016-03-23 |
EP2024747B1 (en) | 2011-06-15 |
ATE513216T1 (de) | 2011-07-15 |
EP2211180A1 (en) | 2010-07-28 |
JP4990970B2 (ja) | 2012-08-01 |
WO2007140966A1 (en) | 2007-12-13 |
JP2009539082A (ja) | 2009-11-12 |
US8465934B2 (en) | 2013-06-18 |
AU2007256391A1 (en) | 2007-12-13 |
US8241859B2 (en) | 2012-08-14 |
JP5301630B2 (ja) | 2013-09-25 |
ES2367412T3 (es) | 2011-11-03 |
EP2211180B1 (en) | 2011-06-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL2211180T3 (pl) | Zastosowanie białka SATB2 jako markera do rozróżniania nowotworów jelita grubego od innych nowotworów | |
WO2010009368A3 (en) | Compositions for the detection and treatment of colorectal cancer | |
WO2010009337A3 (en) | Signatures and pcdeterminants associated with prostate cancer and methods of use thereof | |
WO2006089125A3 (en) | Methods of detecting ovarian cancer | |
WO2008048970A3 (en) | Synthetic antibodies | |
EP1922326A4 (en) | BIOMARKERS USEFUL FOR DIAGNOSING PROSTATE CANCER AND METHOD OF USE THEREOF | |
MX2009005058A (es) | Metodos para tratar, diagnosticar o detectar cancer. | |
WO2009036427A3 (en) | Prostate cancer biomarkers | |
WO2008061213A3 (en) | Genetic variations associated with tumors | |
EP2061899A4 (en) | BIOMARKERS FOR PROSTATE CANCER AND METHOD FOR THEIR USE | |
WO2008097908A3 (en) | Methods of diagnosing and prognosing lung cancer | |
MX2009008470A (es) | Particulas para detectar objetivos intracelulares. | |
EP2611941A4 (en) | GENESIS OF CANCER DIAGNOSIS AND PROGNOSIS | |
WO2009158620A3 (en) | Signatures and determinants associated with metastasis methods of use thereof | |
GB0724881D0 (en) | Methods for the detection of colorectal cancer | |
DE602007009645D1 (de) | Reagenzien und verfahren für krebsprognose und pathologische einstufung | |
PL2140269T3 (pl) | Podpis białkowy/znaczniki do wykrywania gruczolakoraka | |
WO2009140039A3 (en) | Synthetic antibodies | |
IL211255A0 (en) | Cop1 molecules and uses thereof | |
WO2006104912A3 (en) | C-met mutations in lung cancer | |
WO2007149476A3 (en) | Assays for non-apoptotic cell death and uses thereof | |
TNSN08401A1 (en) | Methods of treating diagnosing or detecting cancer | |
MX2009010783A (es) | Deteccion de anaplasma platys. | |
EP2518158A4 (en) | PANCREATIC CANCER MARKERS, METHODS, KITS AND DETECTION BIOPUCES THEREFOR | |
WO2007082073A8 (en) | Biomarkers for oral tongue cancer metastasis and extracapsular spread (ecs) |